Importance of the Hemoglobin Glycation Index for Risk of Cardiovascular and Microvascular Complications and Mortality in Individuals with Type 2 Diabetes (Endocrinol Metab 2024;39:732-47, Claudia Regina Lopes Cardoso et al.)
- PMID: 39736822
- PMCID: PMC11695488
- DOI: 10.3803/EnM.2024.2231
Importance of the Hemoglobin Glycation Index for Risk of Cardiovascular and Microvascular Complications and Mortality in Individuals with Type 2 Diabetes (Endocrinol Metab 2024;39:732-47, Claudia Regina Lopes Cardoso et al.)
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
Importance of the Hemoglobin Glycation Index for Risk of Cardiovascular and Microvascular Complications and Mortality in Individuals with Type 2 Diabetes.Endocrinol Metab (Seoul). 2024 Oct;39(5):732-747. doi: 10.3803/EnM.2024.2001. Epub 2024 Oct 15. Endocrinol Metab (Seoul). 2024. PMID: 39402854 Free PMC article.
References
-
- Hempe JM, Gomez R, McCarter RJ, Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16:313–20. - PubMed
-
- McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004;27:1259–64. - PubMed
-
- Soros AA, Chalew SA, McCarter RJ, Shepard R, Hempe JM. Hemoglobin glycation index: a robust measure of hemoglobin A1c bias in pediatric type 1 diabetes patients. Pediatr Diabetes. 2010;11:455–61. - PubMed
-
- Chalew S, Hempe J, McCarter R. Comment on: Lachin et al. (2007) The hemoglobin glycation index is not an independent predictor of the risk of microvascular complications in the diabetes control and complications trial. Diabetes. 2008;56:1913–1921. 2007. Diabetes 2008;57:e4-author reply e5. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
